MLTX icon

MoonLake Immunotherapeutics

23 hedge funds and large institutions have $190M invested in MoonLake Immunotherapeutics in 2022 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
23
Holders Change
-4
Holders Change %
-14.81%
% of All Funds
0.39%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
15
Increased
5
Reduced
2
Closed
19
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
BCM
26
Beryl Capital Management
California
-$5.1M -459,243 Closed
AWG
27
Alpha Wave Global
New York
-$4.49M -448,882 Closed
APM
28
Avidity Partners Management
Texas
-$4.44M -400,000 Closed
D.E. Shaw & Co
29
D.E. Shaw & Co
New York
-$3.74M -337,021 Closed
TCM
30
Tekla Capital Management
Massachusetts
-$2.78M -250,000 Closed
EC
31
EcoR1 Capital
California
-$2.22M -200,000 Closed
IPCP
32
Iron Park Capital Partners
New York
-$1.79M -179,434 Closed
WAM
33
Weiss Asset Management
Massachusetts
-$1.97M -177,510 Closed
CCM
34
Consonance Capital Management
New York
-$1.52M -137,000 Closed
PMAM
35
Picton Mahoney Asset Management
Ontario, Canada
-$700K -70,000 Closed
Jane Street
36
Jane Street
New York
-$726K -65,437 Closed
FTCM
37
Fir Tree Capital Management
New York
-$619K -61,866 Closed
OAC
38
OMERS Administration Corp
Ontario, Canada
-$513K -46,247 Closed
Nomura Holdings
39
Nomura Holdings
Japan
-$239K -22,733 Closed
E
40
Ergoteles
New York
-$162K -14,613 Closed
CS
41
Clear Street
New York
-$9K -801 Closed